Aura Biosciences, Inc. Number of Reportable Segments
Aura Biosciences, Inc. (AURA) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-11
- Aura Biosciences, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Aura Biosciences, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 Segment.
- Aura Biosciences, Inc. number of reportable segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Aura Biosciences, Inc. number of reportable segments for fiscal 2024 was 1.00 Segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |